{A figure is presented} Long-term fracture risk among women with proven endometriosis

Fertility and Sterility

Volumn 86, Issue 6, 2006, Pages 1576-1583

  Melton III, L Joseph ^a   Leibson, Cynthia L ^a   Good, Andrew E ^a   Achenbach, Sara J ^a   Oberg, Ann L ^a   Khosla, Sundeep ^a  

^a Mayo Clinic   (United States)

Author keywords

Endometriosis; epidemiology; fracture; oophorectomy

Indexed keywords

CORTICOSTEROID; DANAZOL; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORTICOSTEROID THERAPY; COURSE EVALUATION; ENDOMETRIOSIS; FEMALE; FOLLOW UP; FOREARM FRACTURE; HAZARD ASSESSMENT; HIP FRACTURE; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTPATIENT CARE; OVARIECTOMY; PATHOLOGIC FRACTURE; POPULATION RESEARCH; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; SPINE FRACTURE; COMORBIDITY; METHODOLOGY; MIDDLE AGED; PROGNOSIS; RISK FACTOR; UNITED STATES; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; ENDOMETRIOSIS; FEMALE; FOLLOW-UP STUDIES; FRACTURES, SPONTANEOUS; HUMANS; INCIDENCE; MIDDLE AGED; MINNESOTA; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; WOMEN'S HEALTH;

EID: 33751167426     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.05.036     Document Type: Article

References (53)

1. Hernandez C.J., Beaupré G.S., and Carter D.R. A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int 14 (2003) 843-847
2. Gourlay M.L., and Brown S.A. Clinical considerations in premenopausal osteoporosis. Arch Intern Med 164 (2004) 603-614
3. Espallargues M., Sampietro-Colom L., Estrada M.D., Solà M., del Río L., and Setoain J. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int 12 (2001) 811-822
4. Sowers M.F.R., and Galuska D.A. Epidemiology of bone mass in premenopausal women. Epidemiol Rev 15 (1993) 374-398
5. Stevenson J.C. The impact of bone loss in women with endometriosis. Int J Gynecol Obstet 59 Suppl 1 (1995) S11-S15
6. Comite F., Delman M., Hutchinson-Williams K., DeCherney A.H., and Jensen P. Reduced bone mass in reproductive-aged women with endometriosis. J Clin Endocrinol Metab 69 (1989) 837-842
7. Tummon I.S., Ali A., Pepping M.E., Radwanska E., Binor Z., and Dmowski W.P. Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol. Fertil Steril 49 (1988) 792-796
8. Dawood M.Y., Lewis V., and Ramos J. Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol. Fertil Steril 52 (1989) 21-26
9. Lane N., Baptista J., and Orwoll E. Bone mineral density of the lumbar spine in women with endometriosis. Fertil Steril 55 (1991) 537-542
10. Dodin S., Lemay A., Maheux R., Dumont M., and Turcot-Lemay L. Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. Obstet Gynecol 77 (1991) 410-415
11. Surrey E.S., and Judd H.L. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. J Clin Endocrinol Metab 75 (1992) 558-563
12. Rico H., Revilla M., Arnanz F., Villa L.F., Perera S., and Arribas I. Total and regional bone mass value and biochemical markers of bone remodeling in endometriosis. Obstet Gynecol 81 (1993) 272-275
13. Dochi T., Lees B., Sidhu M., and Stevenson J.C. Bone density and endometriosis. Fertil Steril 61 (1994) 175-177
14. Paoletti A.M., Serra G.G., Cagnacci A., Vacca A.M.B., Guerriero S., Solla E., et al. Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. Fertil Steril 65 (1996) 707-710
15. Colacurci N., De Seta L., Passaro M., Scala P., De Franciscis P., and Zarcone R. Bone density in women with endometriosis. Panminerva Med 40 (1998) 126-127
16. Ulrich U., Murano R., Skinner M.A., Yin H., and Chesnut III C.H. Women of reproductive age with endometriosis are not osteopenic. Fertil Steril 69 (1998) 821-825
17. Sagsveen M., Farmer J.E., Prentice A., and Breeze A. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev 4 (2003) CD001297
18. Pierce S.J., Gazvani R., and Farquharson R.G. Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up. Fertil Steril 74 (2000) 964-968
19. Surrey E.S., Hornstein M.D., and Add-Back Study Group. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. Obstet Gynecol 99 (2002) 709-719
20. Surrey E.S., and Add Back Consensus Working Group. Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached?. Fertil Steril 7l (1999) 420-424
21. Melton III L.J., Bergstralh E.J., Malkasian G.D., and O'Fallon W.M. Bilateral oophorectomy trends in Olmsted County, Minnesota, 1950-1987. Epidemiology 2 (1991) 149-152
22. Missmer S.A., and Cramer D.W. The epidemiology of endometriosis. Obstet Gynecol Clin North Am 30 (2003) 1-19
23. Leibson C.L., Good A.E., Hass S.L., Ransom J., Yawn B.P., O'Fallon W.M., et al. Incidence and characterization of diagnosed endometriosis in a geographically defined population. Fertil Steril 82 (2004) 314-321
24. Melton III L.J. History of the Rochester Epidemiology Project. Mayo Clin Proc 71 (1996) 266-274
25. Melton III L.J. The threat to medical-records research. N Engl J Med 337 (1997) 1466-1470
26. Cooper C., Atkinson E.J., O'Fallon W.M., and Melton III L.J. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7 (1992) 221-227
27. Melton III L.J., Crowson C.S., and O'Fallon W.M. Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 9 (1999) 29-37
28. Garraway W.M., Stauffer R.N., Kurland L.T., and O'Fallon W.M. Limb fractures in a defined population. I. Frequency and distribution. Mayo Clin Proc 54 (1979) 701-707
29. Melton III L.J., Sampson J.M., Morrey B.F., and Ilstrup D.M. Epidemiologic features of pelvic fractures. Clin Orthop 155 (1981) 43-47
30. Rose S.H., Melton III L.J., Morrey B.F., Ilstrup D.M., and Riggs B.L. Epidemiologic features of humeral fractures. Clin Orthop 168 (1982) 24-30
31. Arneson T.J., Melton III L.J., Lewallen D.G., and O'Fallon W.M. Epidemiology of diaphyseal and distal femoral fractures in Rochester, Minnesota, 1965-1984. Clin Orthop 234 (1988) 188-194
32. Melton III L.J., Atkinson E.J., and Madhok R. Downturn in hip fracture incidence. Public Health Rep 111 (1996) 146-150
33. Melton III L.J., Amadio P.C., Crowson C.S., and O'Fallon W.M. Long-term trends in the incidence of distal forearm fractures. Osteoporos Int 8 (1998) 341-348
34. Khosla S., Melton III L.J., Dekutoski M.B., Achenbach S.J., Oberg A.L., and Riggs B.L. Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA 290 (2003) 1479-1485
35. Cox D.R. Some simple approximate tests for Poisson variates. Biometrika 40 (1953) 354-360
36. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
37. Kalbfleisch J.D., and Prentice R.L. The statistical analysis of failure time data (1980), Wiley, New York
38. Therneau T.M., and Grambsch P.M. Modeling survival data: extending the Cox model (2000), Springer-Verlag, New York
39. Orwoll E.S., Yuzpe A.A., Burry K.A., Heinrichs L., Buttram Jr. V.C., and Hornstein M.D. Nafarelin therapy in endometriosis: long-term effects on bone mineral density. Am J Obstet Gynecol 171 (1994) 1221-1225
40. Revilla R., Revilla M., Hernández E.R., Villa L.F., Varela L., and Rico H. Evidence that the loss of bone mass induced by GnRH agonists is not totally recovered. Maturitas 22 (1995) 145-150
41. Taga M., and Minagushi H. Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration. Acta Obstet Gynecol Scand 75 (1996) 162-165
42. Riggs B.L., Khosla S., and Melton III L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23 (2002) 279-302
43. Melton III L.J., Lane A.W., Cooper C., Eastell R., O'Fallon W.M., and Riggs B.L. Prevalence and incidence of vertebral deformities. Osteoporos Int 3 (1993) 113-119
44. Melton III L.J., Crowson C.S., Malkasian G.D., and O'Fallon W.M. Fracture risk following bilateral oophorectomy. J Clin Epidemiol 49 (1996) 1111-1115
45. Cummings S.R., and Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359 (2002) 1761-1767
46. van Staa T.P., Leufkens H.G.M., and Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13 (2002) 777-787
47. Klotzbuecher C.M., Ross P.D., Landsman P.B., Abbott III T.A., and Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15 (2000) 721-739
48. Kanis J.A., Johnell O., de Laet C., Johansson H., Oden A., Delmas P., et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 35 (2004) 375-382
49. Beck B.R., Shaw J., and Snow C.M. Chapter 28. Physical activity and osteoporosis. In: Marcus R., Feldman D., and Kelsey J. (Eds). Osteoporosis. 2nd ed Vol. 1 (2001), Academic Press, San Diego 701-720
50. Cranney A., Wells G., Willan A., Griffith L., Zytaruk N., Robinson V., et al. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23 (2002) 508-516
51. Riggs B.L., and Hartmann L.C. Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. N Engl J Med 348 (2003) 618-629
52. Houston D.E., Noller K.L., Melton III L.J., Selwyn B.J., and Hardy R.J. Incidence of pelvic endometriosis in Rochester, Minnesota, 1970-1979. Am J Epidemiol 125 (1987) 959-969
53. Melton III L.J., Atkinson E.J., and Madhok R. Downturn in hip fracture incidence. Public Health Rep 111 (1996) 146-150